The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Intravenous Sedatives Market Research Report 2024

Global Intravenous Sedatives Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1763461

No of Pages : 99

Ask Your Query

Synopsis
A sedative is a drug that works by suppressing the central nervous system.

Global Intravenous Sedatives market is projected to reach US$ 855.6 million in 2029, increasing from US$ 558 million in 2022, with the CAGR of 6.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous Sedatives market research.

Key manufacturers engaged in the Intravenous Sedatives industry include Astrazeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Maruishi, Piramal, Hikma Pharmaceuticals and Mylan, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Intravenous Sedatives were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous Sedatives market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intravenous Sedatives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Astrazeneca
  • Fresenius-Kabi
  • AbbVie
  • Baxter Healthcare
  • B.Braun
  • Maruishi
  • Piramal
  • Hikma Pharmaceuticals
  • Mylan
  • Nhwa
  • Hengrui
  • Lunan
  • Humanwell

Segment by Type

  • Diazepam
  • Midazolam
  • Propofol
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Intravenous Sedatives report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Intravenous Sedatives Market Overview
1.1 Product Overview and Scope of Intravenous Sedatives
1.2 Intravenous Sedatives Segment by Type
1.2.1 Global Intravenous Sedatives Market Value Comparison by Type (2023-2029)
1.2.2 Diazepam
1.2.3 Midazolam
1.2.4 Propofol
1.2.5 Other
1.3 Intravenous Sedatives Segment by Application
1.3.1 Global Intravenous Sedatives Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Intravenous Sedatives Market Size Estimates and Forecasts
1.4.1 Global Intravenous Sedatives Revenue 2018-2029
1.4.2 Global Intravenous Sedatives Sales 2018-2029
1.4.3 Global Intravenous Sedatives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intravenous Sedatives Market Competition by Manufacturers
2.1 Global Intravenous Sedatives Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intravenous Sedatives Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intravenous Sedatives Average Price by Manufacturers (2018-2023)
2.4 Global Intravenous Sedatives Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intravenous Sedatives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravenous Sedatives, Product Type & Application
2.7 Intravenous Sedatives Market Competitive Situation and Trends
2.7.1 Intravenous Sedatives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravenous Sedatives Players Market Share by Revenue
2.7.3 Global Intravenous Sedatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravenous Sedatives Retrospective Market Scenario by Region
3.1 Global Intravenous Sedatives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intravenous Sedatives Global Intravenous Sedatives Sales by Region: 2018-2029
3.2.1 Global Intravenous Sedatives Sales by Region: 2018-2023
3.2.2 Global Intravenous Sedatives Sales by Region: 2024-2029
3.3 Global Intravenous Sedatives Global Intravenous Sedatives Revenue by Region: 2018-2029
3.3.1 Global Intravenous Sedatives Revenue by Region: 2018-2023
3.3.2 Global Intravenous Sedatives Revenue by Region: 2024-2029
3.4 North America Intravenous Sedatives Market Facts & Figures by Country
3.4.1 North America Intravenous Sedatives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intravenous Sedatives Sales by Country (2018-2029)
3.4.3 North America Intravenous Sedatives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravenous Sedatives Market Facts & Figures by Country
3.5.1 Europe Intravenous Sedatives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intravenous Sedatives Sales by Country (2018-2029)
3.5.3 Europe Intravenous Sedatives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravenous Sedatives Market Facts & Figures by Country
3.6.1 Asia Pacific Intravenous Sedatives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intravenous Sedatives Sales by Country (2018-2029)
3.6.3 Asia Pacific Intravenous Sedatives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intravenous Sedatives Market Facts & Figures by Country
3.7.1 Latin America Intravenous Sedatives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intravenous Sedatives Sales by Country (2018-2029)
3.7.3 Latin America Intravenous Sedatives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intravenous Sedatives Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravenous Sedatives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intravenous Sedatives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intravenous Sedatives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intravenous Sedatives Sales by Type (2018-2029)
4.1.1 Global Intravenous Sedatives Sales by Type (2018-2023)
4.1.2 Global Intravenous Sedatives Sales by Type (2024-2029)
4.1.3 Global Intravenous Sedatives Sales Market Share by Type (2018-2029)
4.2 Global Intravenous Sedatives Revenue by Type (2018-2029)
4.2.1 Global Intravenous Sedatives Revenue by Type (2018-2023)
4.2.2 Global Intravenous Sedatives Revenue by Type (2024-2029)
4.2.3 Global Intravenous Sedatives Revenue Market Share by Type (2018-2029)
4.3 Global Intravenous Sedatives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intravenous Sedatives Sales by Application (2018-2029)
5.1.1 Global Intravenous Sedatives Sales by Application (2018-2023)
5.1.2 Global Intravenous Sedatives Sales by Application (2024-2029)
5.1.3 Global Intravenous Sedatives Sales Market Share by Application (2018-2029)
5.2 Global Intravenous Sedatives Revenue by Application (2018-2029)
5.2.1 Global Intravenous Sedatives Revenue by Application (2018-2023)
5.2.2 Global Intravenous Sedatives Revenue by Application (2024-2029)
5.2.3 Global Intravenous Sedatives Revenue Market Share by Application (2018-2029)
5.3 Global Intravenous Sedatives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Astrazeneca
6.1.1 Astrazeneca Corporation Information
6.1.2 Astrazeneca Description and Business Overview
6.1.3 Astrazeneca Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Astrazeneca Intravenous Sedatives Product Portfolio
6.1.5 Astrazeneca Recent Developments/Updates
6.2 Fresenius-Kabi
6.2.1 Fresenius-Kabi Corporation Information
6.2.2 Fresenius-Kabi Description and Business Overview
6.2.3 Fresenius-Kabi Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fresenius-Kabi Intravenous Sedatives Product Portfolio
6.2.5 Fresenius-Kabi Recent Developments/Updates
6.3 AbbVie
6.3.1 AbbVie Corporation Information
6.3.2 AbbVie Description and Business Overview
6.3.3 AbbVie Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AbbVie Intravenous Sedatives Product Portfolio
6.3.5 AbbVie Recent Developments/Updates
6.4 Baxter Healthcare
6.4.1 Baxter Healthcare Corporation Information
6.4.2 Baxter Healthcare Description and Business Overview
6.4.3 Baxter Healthcare Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Healthcare Intravenous Sedatives Product Portfolio
6.4.5 Baxter Healthcare Recent Developments/Updates
6.5 B.Braun
6.5.1 B.Braun Corporation Information
6.5.2 B.Braun Description and Business Overview
6.5.3 B.Braun Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.5.4 B.Braun Intravenous Sedatives Product Portfolio
6.5.5 B.Braun Recent Developments/Updates
6.6 Maruishi
6.6.1 Maruishi Corporation Information
6.6.2 Maruishi Description and Business Overview
6.6.3 Maruishi Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Maruishi Intravenous Sedatives Product Portfolio
6.6.5 Maruishi Recent Developments/Updates
6.7 Piramal
6.6.1 Piramal Corporation Information
6.6.2 Piramal Description and Business Overview
6.6.3 Piramal Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Piramal Intravenous Sedatives Product Portfolio
6.7.5 Piramal Recent Developments/Updates
6.8 Hikma Pharmaceuticals
6.8.1 Hikma Pharmaceuticals Corporation Information
6.8.2 Hikma Pharmaceuticals Description and Business Overview
6.8.3 Hikma Pharmaceuticals Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Hikma Pharmaceuticals Intravenous Sedatives Product Portfolio
6.8.5 Hikma Pharmaceuticals Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mylan Intravenous Sedatives Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Nhwa
6.10.1 Nhwa Corporation Information
6.10.2 Nhwa Description and Business Overview
6.10.3 Nhwa Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nhwa Intravenous Sedatives Product Portfolio
6.10.5 Nhwa Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Corporation Information
6.11.2 Hengrui Intravenous Sedatives Description and Business Overview
6.11.3 Hengrui Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hengrui Intravenous Sedatives Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Lunan
6.12.1 Lunan Corporation Information
6.12.2 Lunan Intravenous Sedatives Description and Business Overview
6.12.3 Lunan Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lunan Intravenous Sedatives Product Portfolio
6.12.5 Lunan Recent Developments/Updates
6.13 Humanwell
6.13.1 Humanwell Corporation Information
6.13.2 Humanwell Intravenous Sedatives Description and Business Overview
6.13.3 Humanwell Intravenous Sedatives Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Humanwell Intravenous Sedatives Product Portfolio
6.13.5 Humanwell Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravenous Sedatives Industry Chain Analysis
7.2 Intravenous Sedatives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravenous Sedatives Production Mode & Process
7.4 Intravenous Sedatives Sales and Marketing
7.4.1 Intravenous Sedatives Sales Channels
7.4.2 Intravenous Sedatives Distributors
7.5 Intravenous Sedatives Customers
8 Intravenous Sedatives Market Dynamics
8.1 Intravenous Sedatives Industry Trends
8.2 Intravenous Sedatives Market Drivers
8.3 Intravenous Sedatives Market Challenges
8.4 Intravenous Sedatives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock